Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -30,050 | -45,710 | -48,560 | -32,780 |
| Depreciation Amortization | N/A | 2,840 | 3,310 | 2,390 | 2,300 |
| Other Working Capital | N/A | -6,930 | -2,500 | 5,970 | 1,630 |
| Other Operating Activity | 0 | 9,870 | 9,410 | 6,720 | 4,200 |
| Operating Cash Flow | $N/A | $-24,270 | $-35,490 | $-33,480 | $-24,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 50 | 90 | -390 | 1,950 |
| Other Investing Activity | 0 | 23,970 | 1,070 | 34,670 | -57,490 |
| Investing Cash Flow | $N/A | $24,020 | $1,160 | $34,280 | $-55,540 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | -190 | -500 | -500 | -500 |
| Other Financing Activity | 0 | -14,210 | 6,620 | 14,510 | 65,880 |
| Financing Cash Flow | $N/A | $-14,400 | $6,120 | $14,010 | $65,380 |
| Beginning Cash Position | N/A | 15,930 | 44,140 | 29,330 | 44,140 |
| End Cash Position | N/A | 1,280 | 15,930 | 44,140 | 29,330 |
| Net Cash Flow | $N/A | $-14,650 | $-28,200 | $14,800 | $-14,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -24,270 | -35,490 | -33,480 | -24,650 |
| Free Cash Flow | 0 | -24,270 | -35,490 | -33,480 | -24,650 |